Literature DB >> 16718694

A mutation in the GABA(A) receptor alpha(1)-subunit is associated with absence epilepsy.

Snezana Maljevic1, Klaus Krampfl, Joana Cobilanschi, Nikola Tilgen, Susanne Beyer, Yvonne G Weber, Friedrich Schlesinger, Daniel Ursu, Werner Melzer, Patrick Cossette, Johannes Bufler, Holger Lerche, Armin Heils.   

Abstract

OBJECTIVE: To detect mutations in GABRA1 in idiopathic generalized epilepsy.
METHODS: GABRA1 was sequenced in 98 unrelated idiopathic generalized epilepsy patients. Patch clamping and confocal imaging was performed in transfected mammalian cells.
RESULTS: We identified the first GABRA1 mutation in a patient with childhood absence epilepsy. Functional studies showed no detectable GABA-evoked currents for the mutant, truncated receptor, which was not integrated into the surface membrane.
INTERPRETATION: We conclude that this de novo mutation can contribute to the cause of "sporadic" childhood absence epilepsy by a loss of function and haploinsufficiency of the GABA(A) receptor alpha(1)-subunit, and that GABRA1 mutations rarely are associated with idiopathic generalized epilepsy. Ann Neurol 2006;59:983-987.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718694     DOI: 10.1002/ana.20874

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  68 in total

1.  The GABAA receptor alpha1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteasomal degradation.

Authors:  Martin J Gallagher; Li Ding; Ankit Maheshwari; Robert L Macdonald
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

2.  Two molecular pathways (NMD and ERAD) contribute to a genetic epilepsy associated with the GABA(A) receptor GABRA1 PTC mutation, 975delC, S326fs328X.

Authors:  Jing-Qiong Kang; Wangzhen Shen; Robert L Macdonald
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

Review 3.  Chloride channels as drug targets.

Authors:  Alan S Verkman; Luis J V Galietta
Journal:  Nat Rev Drug Discov       Date:  2008-01-19       Impact factor: 84.694

4.  ErbB4 reduces synaptic GABAA currents independent of its receptor tyrosine kinase activity.

Authors:  Robert M Mitchell; Megan J Janssen; Irina Karavanova; Detlef Vullhorst; Katrina Furth; Anthony Makusky; Sanford P Markey; Andres Buonanno
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 5.  Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.

Authors:  Hongjie Yuan; Chian-Ming Low; Olivia A Moody; Andrew Jenkins; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

Review 6.  GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition.

Authors:  Tija C Jacob; Stephen J Moss; Rachel Jurd
Journal:  Nat Rev Neurosci       Date:  2008-05       Impact factor: 34.870

7.  Outgrowing seizures in Childhood Absence Epilepsy: time delays and bistability.

Authors:  Yue Liu; John Milton; Sue Ann Campbell
Journal:  J Comput Neurosci       Date:  2019-02-09       Impact factor: 1.621

8.  Decreased viability and absence-like epilepsy in mice lacking or deficient in the GABAA receptor α1 subunit.

Authors:  Fazal M Arain; Kelli L Boyd; Martin J Gallagher
Journal:  Epilepsia       Date:  2012-07-19       Impact factor: 5.864

9.  Genome wide high density SNP-based linkage analysis of childhood absence epilepsy identifies a susceptibility locus on chromosome 3p23-p14.

Authors:  Barry A Chioza; Jean Aicardi; Harald Aschauer; Oebele Brouwer; Petra Callenbach; Athanasios Covanis; Joseph M Dooley; Olivier Dulac; Martina Durner; Orvar Eeg-Olofsson; Martha Feucht; Mogens Laue Friis; Renzo Guerrini; Marianne Juel Kjeldsen; Rima Nabbout; Lina Nashef; Thomas Sander; Auli Sirén; Elaine Wirrell; Paul McKeigue; Robert Robinson; R Mark Gardiner; Kate V Everett
Journal:  Epilepsy Res       Date:  2009-10-17       Impact factor: 3.045

10.  Enhanced tonic GABAA inhibition in typical absence epilepsy.

Authors:  David W Cope; Giuseppe Di Giovanni; Sarah J Fyson; Gergely Orbán; Adam C Errington; Magor L Lorincz; Timothy M Gould; David A Carter; Vincenzo Crunelli
Journal:  Nat Med       Date:  2009-11-22       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.